Assessing medication burden and polypharmacy: finding the perfect measure

Affiliations

¹ a Faculty of Pharmacy and Charles Perkins Centre , University of Sydney , Sydney , NSW , Australia.
² b Department of Internal Medicine , Yale School of Medicine , New Haven , CT , USA.

Editorial

Danijela Gnjidic et al. Expert Rev Clin Pharmacol. 2017 Apr.

. 2017 Apr;10(4):345-347.

doi: 10.1080/17512433.2017.1301206. Epub 2017 Mar 8.

¹ a Faculty of Pharmacy and Charles Perkins Centre , University of Sydney , Sydney , NSW , Australia.
² b Department of Internal Medicine , Yale School of Medicine , New Haven , CT , USA.

Erratum in

Erratum.
[No authors listed] [No authors listed] Expert Rev Clin Pharmacol. 2017 Apr;10(4):i. doi: 10.1080/17512433.2017.1308048. Expert Rev Clin Pharmacol. 2017. PMID: 28322081 No abstract available.

No abstract available

Keywords: Polypharmacy; deprescribing; older adults.

1. Hilmer SN, Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther. 2009;85:86–88. - PubMed
1. Gnjidic D, Hilmer SN, Blyth F, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiology. 2012;65:989–995. - PubMed
1. Gnjidic D, Hilmer SN, Blyth F, et al. High risk prescribing and incidence of frailty among older community-dwelling men. Clin Pharmacol Ther. 2012;91:521–528. - PubMed
1. Kantor ED, Rehm CD, Haas JS, et al. Trends in prescription drug use among adults in the United States from 1999–2012. JAMA. 2015;314:1818–1831. - PMC - PubMed
1. Hubbard RE, Peel NM, Scott IA, et al. Polypharmacy among inpatients aged 70 years or older in Australia. Med J Aust. 2015;202:373–377. - PubMed